PVLA

Palvella Therapeutics, Inc. Common Stock
PVLA

Overview Fund Activity

88 hedge funds and large institutions have $68.8M invested in Palvella Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 33 reducing their positions, and 16 closing their positions.

Holders
88
Holders Change
-8
Holders Change %
-8.33%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
23
Reduced
33
Closed
16
Calls
$67K
Puts
$50K
Net Calls
+$17K
Net Calls Change
+$17K

Top Buyers

1
BI
1
BVF Inc
California
$11.4M
2
SCM
2
Soleus Capital Management
Connecticut
$1.04M
3
Bank of America
3
Bank of America
North Carolina
$576K
4
Russell Investments Group
4
Russell Investments Group
United Kingdom
$555K
5
Assenagon Asset Management
5
Assenagon Asset Management
Luxembourg
$1.4M

Top Sellers

1
SB
1
Samsara BioCapital
California
$0
2
ACM
2
Aquilo Capital Management
California
$7.61M
3
PHP
3
Parkman Healthcare Partners
Connecticut
$0
4
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$0
5
CA
5
Corriente Advisors
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
MAM
101
Meeder Asset Management
Ohio
– -$9K -36 Closed
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
– -$7K -28 Closed
TC
103
Truvestments Capital
Florida
– -$2K -9 Closed
1 2 3 4
5